Biomarker Assay Design & Validation Strategy
Design and validate clinical biomarker assays with regulatory compliance
What You Can Do
You can systematically design clinical biomarker assays by defining biomarker specifications, creating detection protocols, planning validation cohorts, and analyzing performance metrics with statistical rigor. This skill guides you through analytical and clinical validation phases, helping you establish acceptance criteria (sensitivity, specificity, ROC-AUC), develop statistical analysis plans, and generate regulatory-compliant documentation for FDA/EMA submission—reducing rework and accelerating the path from discovery to clinical validation.
Features
Define clinical context, intended use, and performance thresholds before assay design
Structure sensitivity, specificity, linearity, and reproducibility studies with acceptance criteria
Size cohorts statistically for adequate positive/negative controls and clinical decision-making
Define primary/secondary endpoints, power calculations, and hypothesis testing strategies
Calculate and interpret ROC curves, PPV/NPV, concordance, and clinical utility indices
Generate compliance-ready protocols, study designs, and submission summaries for FDA/EMA pathways
Design assay workflows for biomarker combinations with interaction analysis
Structure and power studies using archived samples or electronic health records
Example Output
Example 1: Analytical Validation Protocol
- Assay: ALK fusion detection in NSCLC tumors
- Acceptance criteria: ≥95% sensitivity, ≥99% specificity in 50 positive/50 negative samples
- Methods: FISH validation against ddPCR gold standard with 10% discordant panel
- Statistical analysis: Fisher's exact test for sensitivity/specificity; ROC-AUC with 95% CI
Example 2: Clinical Validation Study Design
- Biomarker: 4-protein signature for treatment response prediction
- Sample size: 200 patients (80% power, α=0.05) for primary endpoint of 70% PPV
- Cohort: Retrospective, stratified by disease stage; prospective validation phase planned
- Primary analysis: Logistic regression with biomarker score as predictor; ROC-AUC comparison to standard care
Example 3: Regulatory Submission Summary
- Device: LDT for circulating tumor DNA burden in metastatic colorectal cancer
- Clinical context: Monitoring response to immunotherapy
- Performance data: 94% sensitivity, 96% specificity; 0.91 ROC-AUC in validation cohort
- Submission strategy: 510(k) pathway with two clinical studies supporting analytical and clinical validity
What's Included
- SKILL.md instruction file with core workflow phases and decision trees:
- Biomarker Specification Template: clinical context, intended use statement, performance thresholds
- Analytical Validation Protocol Framework: study designs for sensitivity, specificity, linearity, reproducibility
- Statistical Analysis Plan (SAP) Checklist: primary endpoints, power calculations, analysis populations, hypothesis tests
- Regulatory Documentation Checklist: FDA 510(k), EMA IVD protocols, and clinical evidence summaries
- Performance Metrics Worksheet: ROC curve, PPV/NPV, concordance, and decision curve analysis templates
Who It's For
- Bioinformatics scientists designing clinical biomarker assays and validation studies
- R&D managers transitioning biomarkers from research to clinical development pipelines
- Regulatory affairs specialists preparing biomarker submissions for FDA/EMA approval
- Clinical laboratory directors developing new liquid or tissue biomarker panels
- Biotech/pharma project leaders planning companion diagnostic assay validation programs
Best For
- Designing end-to-end analytical and clinical validation studies for single or multi-marker assays
- Creating statistical analysis plans and power calculations for biomarker cohorts
- Defining acceptance criteria (sensitivity, specificity, ROC-AUC) for assay performance
- Generating regulatory-compliant protocols and documentation for FDA/EMA submissions
- Planning retrospective or prospective validation cohorts from existing samples or health records
You might also like
You can submit tool designs—drawings, specifications, or descriptions—and Claude will evaluate manufacturability constraints, identify potential failure modes using structured frameworks, and recommend cost-reduction opportunities. You'll receive a prioritized report covering structural analysis, production feasibility, material efficiency, and design trade-offs.
by kody-w
You can take unstructured monitoring visit observations and convert them into formal, audit-ready reports that categorize findings by risk level (Critical, Major, Minor), validate protocol compliance, and generate actionable follow-up items with assigned owners and resolution dates. The skill ensures your documentation meets FDA inspection standards and ICH-GCP requirements while creating clear escalation pathways for high-risk issues.
by kody-w
You can automate the validation of clinical trial data against protocol specifications, identify discrepancies including missing values, out-of-range results, protocol violations, and CRF inconsistencies. The skill generates audit-ready query documentation, categorizes anomalies by severity and type, resolves root causes systematically, and produces FDA inspection-ready reports that trace every data decision and corrective action for CDISC and regulatory submission.
by kody-w
You can submit raw mass spectrometry observations, instrument parameters, or sample preparation details to Claude and receive targeted diagnostic frameworks that explain anomalous results. Claude systematically generates plausible mechanistic explanations for unexpected protein abundance patterns, quantification inconsistencies, and PTM findings—then helps you design minimal, hypothesis-driven troubleshooting experiments to test them.
by kody-w
You can validate eCRF and paper CRF datasets against protocol-defined rules, automatically identify data discrepancies (missing fields, out-of-range values, date inconsistencies), generate structured Data Query Forms (DQFs) for site clarification, track resolution status, and create audit-ready compliance documentation that meets FDA 21 CFR Part 11 and GCP requirements. This workflow reduces manual validation time while ensuring 100% traceability and regulatory readiness for inspections.
by kody-w
Get comprehensive PCB design analysis covering power delivery networks, signal integrity, thermal management, and manufacturing constraints. Claude identifies potential issues early and provides specific, actionable optimization recommendations to reduce cost, improve reliability, and accelerate time-to-market. Suitable for designs from initial concept through production-ready layouts.
by kody-w
You consolidate parallel data streams from preclinical toxicology studies (clinical pathology, histopathology, body weight changes, organ weights, clinical observations, mortality) into coherent regulatory-compliant narratives. This skill synthesizes findings across 6–12 endpoints simultaneously, identifies NOAEL/LOAEL with biological justification, determines safety margins, interprets species-specific or sex-specific signals, and produces Results & Discussion sections that satisfy FDA/EMA reviewers while supporting appropriate dosing decisions for IND-enabling studies.
by kody-w
This skill systematically analyzes your product designs to identify manufacturability issues early, saving costly revisions and manufacturing delays. It evaluates geometry, material selection, tolerances, assembly feasibility, and production process constraints. You get actionable feedback on cost drivers, process risks, and design optimizations before committing to production.
by kody-w